<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2954-3835</journal-id>
<journal-title><![CDATA[Cardiovascular and metabolic science]]></journal-title>
<abbrev-journal-title><![CDATA[Cardiovasc. metab. sci]]></abbrev-journal-title>
<issn>2954-3835</issn>
<publisher>
<publisher-name><![CDATA[Asociación Nacional de Cardiólogos de México A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2954-38352019000100028</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Reperfusion in acute myocardial infarction in the elderly (clinical characteristics and prognosis). Results of the IMSS Nuevo León Infarction Code Program]]></article-title>
<article-title xml:lang="es"><![CDATA[Reperfusión en el infarto agudo de miocardio en ancianos (características clínicas y pronóstico). Resultados del Programa Código Infarto del IMSS Nuevo León]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zapata Ruiz]]></surname>
<given-names><![CDATA[Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Palacios Rodríguez]]></surname>
<given-names><![CDATA[Juan Manuel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cruz Obregón]]></surname>
<given-names><![CDATA[Ramón De la]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arboine Aguirre]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sierra Fragoso]]></surname>
<given-names><![CDATA[Ángel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Muñoz Consuegra]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Unidad Médica de Alta Especialidad Hospital de Cardiología No. 34 Departamento de Hemodinámica e Intervencionismo]]></institution>
<addr-line><![CDATA[Monterrey N.L]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Unidad Médica de Alta Especialidad Hospital de Cardiología No. 34 Departamento de Hemodinámica e Intervencionismo]]></institution>
<addr-line><![CDATA[Monterrey N.L]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Unidad Médica de Alta Especialidad Hospital de Cardiología No. 34 Departamento de Hemodinámica e Intervencionismo]]></institution>
<addr-line><![CDATA[Monterrey N.L]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<volume>30</volume>
<numero>1</numero>
<fpage>28</fpage>
<lpage>33</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2954-38352019000100028&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2954-38352019000100028&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2954-38352019000100028&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  The age is an important prognostic factor in patients with acute myocardial infarction. As there are no data in the Mexican population, it is important to establish the characteristics and prognosis of older adults in whom mechanical reperfusion treatment is carried out. Methods and results: We carried out a retrospective analysis from January 1, 2016 to December 31, 2017 in which a total of 1,025 patients were included in the Infarction Code Program and received a myocardial reperfusion treatment, being the 15.3% over the age of 75 years of our patients. The age range was 33 to 92 years. The mortality rate increased exponentially with age (3.4% for patients &#8804; 54 years, 6.1% for 55 to 64 years, 9.2% for 65 to 75 years and 15.9% for &#8805; 75 years, p &lt; 0.001). In patients older than 75 years-old, primary angioplasty is the preferred method of reperfusion (77.7%), without an increase in cerebrovascular events. Over the age of 75 years-old, patients who develop cardiogenic shock have a higher mortality compared with younger ones (17.6, 28, 33 vs 56%, p &lt; 0.001).  Conclusions:  Despite the different treatments of reperfusion, mortality remains higher in older adults, mainly due to multiple comorbidities and a higher rate of ventricular dysfunction.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  La edad es un factor pronóstico en los pacientes con infarto agudo de miocardio. Al no encontrar datos similares en la población mexicana, se busca establecer las características y pronóstico de los adultos mayores llevados a tratamiento de reperfusión mecánica. Métodos y resultados: Se llevó a cabo un análisis retrospectivo de enero de 2016 al 31 de diciembre 2017 en el que se incluyeron un total de 1,025 pacientes en el programa Código Infarto llevados a tratamiento de reperfusión, siendo el 15.3% mayores de 75 años. El rango de edad fue de los 33 a los 92 años. La mortalidad aumentó de forma exponencial a mayor edad (3.4% para los pacientes &#8804; 54 años, 6.1% para 55 a 64 años, 9.2% para 65 a 75 años y 15.9% para los &#8805; 75 años, p &lt; 0.001). En los pacientes mayores de 75 años, la angioplastia primaria es el método de reperfusión preferido (77.7%), sin encontrar en este grupo de pacientes un aumento en el número de eventos vasculares cerebrales. Los pacientes mayores de 75 años que desarrollan choque cardiogénico tienen una mortalidad mucho mayor comparada con los más jóvenes (17.6, 28, 33 vs 56%, p &lt; 0.001).  Conclusiones:  A pesar de los diferentes tratamientos de reperfusión, la mortalidad sigue siendo más elevada en los adultos de edad avanzada, principalmente por múltiples comorbilidades y una tasa más alta de disfunción ventricular.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Coronary angioplasty]]></kwd>
<kwd lng="en"><![CDATA[stent]]></kwd>
<kwd lng="en"><![CDATA[elderly]]></kwd>
<kwd lng="en"><![CDATA[acute myocardial infarction]]></kwd>
<kwd lng="es"><![CDATA[Angioplastia coronaria]]></kwd>
<kwd lng="es"><![CDATA[stent]]></kwd>
<kwd lng="es"><![CDATA[ancianos]]></kwd>
<kwd lng="es"><![CDATA[infarto agudo de miocardio]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shanmugam]]></surname>
<given-names><![CDATA[VB]]></given-names>
</name>
<name>
<surname><![CDATA[Harper]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An overview of PCI in the very elderly]]></article-title>
<source><![CDATA[J Geriatr Cardiol]]></source>
<year>2015</year>
<volume>12</volume>
<page-range>174-84</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[TY]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Peterson]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Percutaneous coronary intervention in the elderly]]></article-title>
<source><![CDATA[Nat Rev Cardiol]]></source>
<year>2011</year>
<volume>8</volume>
<page-range>79-90</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ibanez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Agewall]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bucciarelli-Ducci]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bueno]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2018</year>
<volume>39</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>119-77</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levine]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
<name>
<surname><![CDATA[Bates]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2011</year>
<volume>58</volume>
<page-range>e44-122</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Percutaneous coronary intervention using transradial access in elderly vs. non-elderly patients]]></article-title>
<source><![CDATA[Rev Bras Cardiol Invasiva]]></source>
<year>2013</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>36-42</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thiemann]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Coresh]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Shulman]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2000</year>
<volume>101</volume>
<page-range>2239-46</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Capodanno]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Angiolillo]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antithrombotic therapy in the elderly]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2010</year>
<volume>56</volume>
<page-range>1683-92</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hsieh]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Jolly]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Should radial access be the preferred approach in the elderly?]]></article-title>
<source><![CDATA[Rev Bras Cardiol Invasiva]]></source>
<year>2012</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sim]]></surname>
<given-names><![CDATA[WL]]></given-names>
</name>
<name>
<surname><![CDATA[Mutha]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical characteristics and outcomes of octogenarians presenting with ST elevation myocardial infarction in the Australian population]]></article-title>
<source><![CDATA[World J Cardiol]]></source>
<year>2017</year>
<volume>9</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>437-41</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guagliumi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Stone]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
<name>
<surname><![CDATA[Cox]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction, results from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2004</year>
<volume>110</volume>
<page-range>1598-604</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
